Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
Sander Mertens(University Medical Center Utrecht), Hugo J.G. Snippert(Oncode Institute), Natalie Proost(The Netherlands Cancer Institute), Carla S. Veríssimo(Leiden University Medical Center), Olaf van Tellingen(Dutch Cancer Society), René Overmeer, Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Jeanine M.L. Roodhart(University Medical Center Utrecht), Bas Ponsioen(Utrecht University), Sylvia F. Boj(Royal Netherlands Academy of Arts and Sciences), Maarten A. Huismans(Utrecht University), Marieke van de Ven(The Netherlands Cancer Institute), Harry Begthel(Hubrecht Institute for Developmental Biology and Stem Cell Research), Johannes L. Bos(University Medical Center Utrecht)
Cited by 72